Theriva Biologics, Inc. Other Nonoperating Income (Expense)
Theriva Biologics, Inc. (TOVX) reported Other Nonoperating Income (Expense) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-02.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2017-03-02
- Theriva Biologics, Inc. other nonoperating income (expense) for the quarter ending 2015-12-31 was $0.00.
- Theriva Biologics, Inc. other nonoperating income (expense) for the quarter ending 2015-09-30 was $0.00.
- Theriva Biologics, Inc. other nonoperating income (expense) for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. other nonoperating income (expense) for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. other nonoperating income (expense) for fiscal 2016 was $0.00.
- Theriva Biologics, Inc. other nonoperating income (expense) for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Theriva Biologics, Inc. other nonoperating income (expense) for fiscal 2014 was $95.00K.
- Theriva Biologics, Inc. other nonoperating income (expense) for fiscal 2013 was -$12.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-02 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $95.00K derived: sum of 3 quarters · filed 2017-03-02 | $95.00K 10-K · filed 2017-03-02 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $95.00K derived: sum of 2 quarters · filed 2015-11-05 | $95.00K 10-Q · filed 2015-11-05 | $142.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $95.00K 10-Q · filed 2015-08-10 | $95.00K 10-Q · filed 2015-08-10 | $142.00K derived: sum of 3 quarters · filed 2016-03-10 | $128.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $47.00K derived: sum of 2 quarters · filed 2016-03-10 | $33.00K derived: sum of 3 quarters · filed 2016-03-10 | -$13.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $33.00K derived: sum of 2 quarters · filed 2016-03-10 | -$13.00K derived: sum of 3 quarters · filed 2016-03-10 | -$12.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | -$14.00K 10-Q · filed 2014-11-14 | -$60.00K derived: sum of 2 quarters · filed 2014-11-14 | -$59.00K 10-Q · filed 2014-11-14 | -$99.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$46.00K 10-Q · filed 2014-08-14 | -$45.00K 10-Q · filed 2014-08-14 | -$85.00K derived: sum of 3 quarters · filed 2015-03-16 | -$75.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-15 | -$39.00K derived: sum of 2 quarters · filed 2015-03-16 | -$29.00K derived: sum of 3 quarters · filed 2015-03-16 | -$22.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$30.00K derived: sum of 2 quarters · filed 2015-03-16 | -$23.00K derived: sum of 3 quarters · filed 2015-03-16 | -$18.00K 10-K · filed 2015-03-16 |
| 2012-09-30 | $10.00K 10-Q · filed 2013-11-14 | $17.00K derived: sum of 2 quarters · filed 2013-11-14 | $22.00K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $7.00K 10-Q · filed 2013-08-14 | $12.00K 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | $5.00K 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | $22.00K 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |